SEC Form 4 · accession 0001209784-17-000057
ORASURE TECHNOLOGIES INC · OSUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
II Anthony Zezzo
Officer — EVP - Infectious Diseases
Period of report
Aug 7, 2017
Accepted (ET)
Aug 9, 2017 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001116463
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Aug 7, 2017 | M | 72,916 | $5.7149 | A | 218,326 | D | |
| Common stock | Aug 7, 2017 | S | 72,916 | $21.2614 | D | 145,410 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonqualified stock optionsF1 | $5.7149 | Aug 7, 2017 | M | 72,916 | D | — | Feb 3, 2024 | Common stock | 72,916 | 10,427 | D |
Explanation of responses
- F1Nonqualified stock options granted on February 3, 2014 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.